发布于: 雪球转发:0回复:1喜欢:0
受益于ASCO2015,盘前涨15%。
引用:
2015-05-14 10:48
$赛瑞恩肿瘤药剂(ONTY)$ ONT-380效果不错,总共8例乳腺癌患者,partial response (PR) n = 4, stable disease (SD) n = 2, and progressive disease n = 2. Two pts with PR and 2 pts with SD also had received prior pertuzumab.

全部讨论

2015-05-14 21:47

juno怎么没受益呢